Peripheral Arterial Disease Trial, Recruiting NCT06041880 Sponsor: Penn State University Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Peripheral Arterial Disease Trial, Recruiting

NCT06041880
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with peripheral artery disease (PAD), a condition affecting blood flow in the legs
  • Your PAD symptoms have been stable for at least 3 months
  • You are between 40 and 85 years old
  • You are a man or a woman who is not currently pregnant or breastfeeding

Who may not be able to join:

  • You have leg pain at rest, or have open sores or tissue death in your legs due to poor blood flow
  • You have another condition (not PAD) that makes it hard for you to walk
  • You have had major surgery or a procedure to restore blood flow in your legs within the past 6 months
  • You have had a heart attack in the past 6 months or have unstable chest pain
  • You have severe lung disease and need oxygen or frequently use emergency inhalers
  • Your blood vessels in the legs cannot be properly compressed during a routine circulation test (confirm with trial site)
  • You already exercise regularly — meaning 30 or more minutes of continuous activity on 3 or more days per week
  • You currently smoke or use any products containing nicotine
  • You are pregnant or breastfeeding
  • You have had ankle surgery or reconstruction, or have had an injury to your ankle, Achilles tendon, or feet within the past year
  • You have rheumatoid arthritis or another disease that causes joint damage
  • You have been treated for a serious medical illness within the past 12 months
  • Your blood pressure is not well controlled
  • Your diabetes is not well controlled
  • You are unable to walk on a treadmill at a very slow pace (1 mile per hour)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 814-571-5234

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Penn State University
Registry
ClinicalTrials.gov
Start date
1 April 2024
Est. completion
1 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

6-minute walk test distance; Muscle to tendon ratio; Endothelial function

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov